Email updates

Keep up to date with the latest news and content from Cancer Cell International and BioMed Central.

Open Access Correction

Correction: MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer

Jia Li, Xiangjie Kong, Junfeng Zhang, Qifeng Luo, Xiaoyu Li and Lin Fang*

Author Affiliations

Department of Breast and Thyroid, Shanghai Tenth People’s Hospital, Shanghai, 200072, China

For all author emails, please log on.

Cancer Cell International 2013, 13:17  doi:10.1186/1475-2867-13-17


The electronic version of this article is the complete one and can be found online at: http://www.cancerci.com/content/13/1/17


Received:20 February 2013
Accepted:20 February 2013
Published:21 February 2013

© 2013 Li et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Correction

After publication of this article [1], the authors noted an error in Figure http://1 webcite. The labelling of normal tissues and cancer tissues was inverted. Please see Figure 1 for the corrected version. The authors apologise for any inconvenience this has caused.

thumbnailFigure 1. miR-26b is relatively downregulated in breast cancer.

References

  1. Li J, Kong X, Zhang J, Luo Q, Li X, Fang L: MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.

    Cancer Cell Int 2013, 13:7. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL